Cell Reports (Jan 2025)
The adaptor protein Miro1 modulates horizontal transfer of mitochondria in mouse melanoma models
- Jaromir Novak,
- Zuzana Nahacka,
- Gabriela L. Oliveira,
- Petra Brisudova,
- Maria Dubisova,
- Sarka Dvorakova,
- Sona Miklovicova,
- Marketa Dalecka,
- Verena Puttrich,
- Lenka Grycova,
- Silvia Magalhaes-Novais,
- Catarina Mendes Correia,
- Jennifer Levoux,
- Ludek Stepanek,
- Jan Prochazka,
- David Svec,
- David Pajuelo Reguera,
- Guillermo Lopez-Domenech,
- Renata Zobalova,
- Radek Sedlacek,
- Mikkel G. Terp,
- Payam A. Gammage,
- Zdenek Lansky,
- Josef Kittler,
- Paulo J. Oliveira,
- Henrik J. Ditzel,
- Michael V. Berridge,
- Anne-Marie Rodriguez,
- Stepana Boukalova,
- Jakub Rohlena,
- Jiri Neuzil
Affiliations
- Jaromir Novak
- Institute of Biotechnology, Czech Academy of Sciences, 252 50 Prague-West, Czech Republic; Faculty of Science, Charles University, 128 00 Prague, Czech Republic
- Zuzana Nahacka
- Institute of Biotechnology, Czech Academy of Sciences, 252 50 Prague-West, Czech Republic; Corresponding author
- Gabriela L. Oliveira
- Institute of Biotechnology, Czech Academy of Sciences, 252 50 Prague-West, Czech Republic; NC-UC, Center for Neuroscience and Cell Biology, University of Coimbra, 3060-197 Cantanhede, Portugal; CIBB, Centre for Innovative Biomedicine and Biotechnology, University of Coimbra, 3060-197 Cantanhede, Portugal; Institute for Interdisciplinary Research, Doctoral Program in Experimental Biology and Biomedicine (PDBEB), University of Coimbra, 3060-197 Cantanhede, Portugal
- Petra Brisudova
- Institute of Biotechnology, Czech Academy of Sciences, 252 50 Prague-West, Czech Republic; Faculty of Science, Charles University, 128 00 Prague, Czech Republic
- Maria Dubisova
- Institute of Biotechnology, Czech Academy of Sciences, 252 50 Prague-West, Czech Republic; Faculty of Science, Charles University, 128 00 Prague, Czech Republic
- Sarka Dvorakova
- Institute of Biotechnology, Czech Academy of Sciences, 252 50 Prague-West, Czech Republic
- Sona Miklovicova
- Institute of Biotechnology, Czech Academy of Sciences, 252 50 Prague-West, Czech Republic; Faculty of Science, Charles University, 128 00 Prague, Czech Republic
- Marketa Dalecka
- Faculty of Science, Charles University, 128 00 Prague, Czech Republic
- Verena Puttrich
- Institute of Biotechnology, Czech Academy of Sciences, 252 50 Prague-West, Czech Republic
- Lenka Grycova
- Institute of Biotechnology, Czech Academy of Sciences, 252 50 Prague-West, Czech Republic
- Silvia Magalhaes-Novais
- Institute of Biotechnology, Czech Academy of Sciences, 252 50 Prague-West, Czech Republic; Czech Center for Phenogenomic, Institute of Molecular Genetics, Czech Academy of Sciences, 252 50 Vestec, Czech Republic
- Catarina Mendes Correia
- Cancer Research UK Scotland Institute, Glasgow G61 1BD, UK
- Jennifer Levoux
- Sorbonne University, Institute of Biology Paris-Seine, 75005 Paris, France
- Ludek Stepanek
- Czech Center for Phenogenomic, Institute of Molecular Genetics, Czech Academy of Sciences, 252 50 Vestec, Czech Republic
- Jan Prochazka
- Czech Center for Phenogenomic, Institute of Molecular Genetics, Czech Academy of Sciences, 252 50 Vestec, Czech Republic
- David Svec
- Institute of Biotechnology, Czech Academy of Sciences, 252 50 Prague-West, Czech Republic
- David Pajuelo Reguera
- Czech Center for Phenogenomic, Institute of Molecular Genetics, Czech Academy of Sciences, 252 50 Vestec, Czech Republic
- Guillermo Lopez-Domenech
- Department of Neuroscience, Physiology and Pharmacology, University College London, Gower Street, London WC1E 6BT, UK
- Renata Zobalova
- Institute of Biotechnology, Czech Academy of Sciences, 252 50 Prague-West, Czech Republic
- Radek Sedlacek
- Czech Center for Phenogenomic, Institute of Molecular Genetics, Czech Academy of Sciences, 252 50 Vestec, Czech Republic
- Mikkel G. Terp
- Institute of Molecular Medicine, University of Southern Denmark, 5000 Odense, Denmark
- Payam A. Gammage
- Cancer Research UK Scotland Institute, Glasgow G61 1BD, UK; School of Cancer Sciences, University of Glasgow, Glasgow G61 1BD, UK
- Zdenek Lansky
- Institute of Biotechnology, Czech Academy of Sciences, 252 50 Prague-West, Czech Republic
- Josef Kittler
- Department of Neuroscience, Physiology and Pharmacology, University College London, Gower Street, London WC1E 6BT, UK
- Paulo J. Oliveira
- NC-UC, Center for Neuroscience and Cell Biology, University of Coimbra, 3060-197 Cantanhede, Portugal; CIBB, Centre for Innovative Biomedicine and Biotechnology, University of Coimbra, 3060-197 Cantanhede, Portugal
- Henrik J. Ditzel
- Institute of Molecular Medicine, University of Southern Denmark, 5000 Odense, Denmark; Department of Oncology, Odense University Hospital, 5000 Odense, Denmark
- Michael V. Berridge
- Malaghan Institute of Medical Research, Wellington 6012, New Zealand
- Anne-Marie Rodriguez
- Sorbonne University, Institute of Biology Paris-Seine, 75005 Paris, France; University Paris-Est Créteil, INSERM, IMRB, 94010 Créteil, France
- Stepana Boukalova
- Institute of Biotechnology, Czech Academy of Sciences, 252 50 Prague-West, Czech Republic; Faculty of Science, Charles University, 128 00 Prague, Czech Republic
- Jakub Rohlena
- Institute of Biotechnology, Czech Academy of Sciences, 252 50 Prague-West, Czech Republic
- Jiri Neuzil
- Institute of Biotechnology, Czech Academy of Sciences, 252 50 Prague-West, Czech Republic; Faculty of Science, Charles University, 128 00 Prague, Czech Republic; School of Pharmacy and Medical Science, Griffith University, Southport, QLD 4222, Australia; 1st Faculty of Medicine, Charles University, 121 08 Prague, Czech Republic; Corresponding author
- Journal volume & issue
-
Vol. 44,
no. 1
p. 115154
Abstract
Summary: Recent research has shown that mtDNA-deficient cancer cells (ρ0 cells) acquire mitochondria from tumor stromal cells to restore respiration, facilitating tumor formation. We investigated the role of Miro1, an adaptor protein involved in movement of mitochondria along microtubules, in this phenomenon. Inducible Miro1 knockout (Miro1KO) mice markedly delayed tumor formation after grafting ρ0 cancer cells. Miro1KO mice with fluorescently labeled mitochondria revealed that this delay was due to hindered mitochondrial transfer from the tumor stromal cells to grafted B16 ρ0 cells, which impeded recovery of mitochondrial respiration and tumor growth. Miro1KO led to the perinuclear accumulation of mitochondria and impaired mobility of the mitochondrial network. In vitro experiments revealed decreased association of mitochondria with microtubules, compromising mitochondrial transfer via tunneling nanotubes (TNTs) in mesenchymal stromal cells. Here we show the role of Miro1 in horizontal mitochondrial transfer in mouse melanoma models in vivo and its involvement with TNTs.